Schisandrin alleviates the cognitive impairment in rats with Alzheimer’s disease by altering the gut microbiota composition to modulate the levels of endogenous metabolites in the plasma, brain, and feces
Schisandrin is one of the main active compounds isolated from the fruit of Schisandrae chinensis Fructus, which is scientifically proven to have beneficial effects on Alzheimer’s disease (AD) treatment at the cellular and whole organism level. However, the oral availability of schisandrin is very lo...
Main Authors: | Chengqin Zhang, Ying Zhang, Tiantian Zhao, Tingting Mou, Wang Jing, Jian Chen, Wenqian Hao, Shuo Gu, Meirong Cui, Yue Sun, Binbin Wei |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2022-09-01
|
Series: | Frontiers in Pharmacology |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fphar.2022.888726/full |
Similar Items
-
Therapeutic effect of Schisandrin A on avian colibacillosis through gut-liver axis
by: Jialu Bao, et al.
Published: (2021-10-01) -
Schisandrin Inhibits NLRP1 Inflammasome-Mediated Neuronal Pyroptosis in Mouse Models of Alzheimer’s Disease
by: Li Q, et al.
Published: (2021-01-01) -
Combined with UPLC-Triple-TOF/MS-based plasma lipidomics and molecular pharmacology reveals the mechanisms of schisandrin against Alzheimer’s disease
by: Tian-tian Zhao, et al.
Published: (2023-02-01) -
In Silico Analysis, Anticonvulsant Activity, and Toxicity Evaluation of Schisandrin B in Zebrafish Larvae and Mice
by: Dorota Nieoczym, et al.
Published: (2023-08-01) -
Inhibitory effect of Schisandrin on the pharmacokinetics of poziotinib in vivo and in vitro by UPLC‐MS/MS
by: Shuanghu Wang, et al.
Published: (2023-05-01)